Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

Duke Rohlen - aVenture Research

Duke Rohlen

AddedMar 31, 2024

UpdatedOct 18, 2026

Duke Rohlen

Duke Rohlen

Co-Founder & CEO, Zeus Health

Duke Rohlen's Career

Zeus Health

Menlo Park, CA, US

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

Duke Rohlen's Investments

1 investments since 2017

1 operating

Investments view

Group by

2017

1

Ajax Health
Series A · January 2017$95M
Series A · January 2017

Board Member· Board

Co-Founder & CEO· C-Suite · Management

Co-Founder

Verix Health

Series A$8.2MPhiladelphia, PA, US

Board Member· Board

CEO· C-Suite · Management

Atriomx

Series A$11MMenlo Park, CA, US

CEO· C-Suite · Management

Ablacon

Series B$63.5MWheat Ridge, CO, US

Board Member· Board

CEO· C-Suite · Management

Ajax Health

Series C$315MMenlo Park, CA, US

Founder & CEO· C-Suite · Management

Founder

People Similar to Duke Rohlen

Aroon KrishnaFounder · Axiom Health

James M GarveyBoard Member · SV Health Investors

Mike CarrelBoard Member · Axonics

Chris VelisCEO · MedCap Advisors

Burke T BarrettBoard Member · CardioFocus

Mike HoovenCo-Founder · AtriCure

Bruce RobertsonBoard Member · Exagen

Leadership at Zeus Health

Philip WicklineCo-Founder

Similar to Zeus Health

Zenith Technical InnovationsGurnee, IL, USMedical Devicesest. 2014Zenith Technical InnovationsGurnee, IL, US · est. 2014

Zenith Technical Innovations: Illinois-based medical device manufacturer and distributor, specializing in versatile therapy solutions.

Piraeus MedicalRochester, MN, USMedical Devicesest. 2021Piraeus MedicalRochester, MN, US · est. 2021

Piraeus Medical: A stealth-mode healthcare company creating devices for enhanced patient care.

ZeptoSan Francisco, CA, USMedical Devicesest. 2005ZeptoSan Francisco, CA, US · est. 2005

Mynosys Cellular Devices: A global ophthalmic tech firm from Fremont, US, enhancing surgical procedures.

Series B · $29M30

ZetaRx BiosciencesSeattle, WA, USMedicalest. 2009ZetaRx BiosciencesSeattle, WA, US · est. 2009

Seattle-based medical organization specializing in healthcare sector since 2009.

Similar to Verix Health

Current SurgicalWashington, D.C., DC, USSurgical Devicesest. 2020Current SurgicalWashington, D.C., DC, US · est. 2020

Current Surgical, founded in 2020, develops precise microinvasive tools for solid tumor treatment.

Angel · $3.9M2

NovaTract SurgicalMadison, CT, USMedical Devicesest. 2010NovaTract SurgicalMadison, CT, US · est. 2010

NovaTract Surgical develops laparoscopic devices for minimally invasive surgeries across the US.

Series A · $4.7M8

SanovasSan Rafael, CA, USSurgical Toolsest. 2009SanovasSan Rafael, CA, US · est. 2009

Sanovas, Inc. develops and offers minimally invasive surgical tools for complex medical procedures in the US.

Series A · $9.2M39

Virtuoso SurgicalNashville, TN, USSurgical Roboticsest. 2016Virtuoso SurgicalNashville, TN, US · est. 2016

Virtuoso Surgical develops advanced endoscopic robotic tools for minimally invasive surgeries.

Similar to Atriomx

InnerpulseTriangle (historical), NC, USMedical Devicesest. 2003InnerpulseTriangle (historical), NC, US · est. 2003

InnerPulse, Inc.: Innovating cardiac arrhythmia treatment through advanced technology and devices.

Series D · $50M8

Atrility MedicalMadison, WI, USMedical Devicesest. 2017Atrility MedicalMadison, WI, US · est. 2017

Cardiac device manufacturer setting new standards in arrhythmia monitoring with AtriAmp.

Series A · $4M9

CoreMapBurlington, VT, USMedical Devicesest. 2016CoreMapBurlington, VT, US · est. 2016

CoreMap: Enhancing patient outcomes with advanced diagnostic technology for electrophysiologists.

Series B · $33.8M35

CardioPhiMilpitas, CA, USSoftwareCardioPhiMilpitas, CA, US

California-based CardioPhi develops software to enhance cardiac arrhythmia outcomes, reducing healthcare costs.

Leadership at Ablacon

Peter RuppersbergFounder

Similar to Ablacon

CortexSanta Clara, CA, USMedical Softwareest. 2023CortexSanta Clara, CA, US · est. 2023

Cortex, a California-based software company, innovates precise, simple, and fast AFib assessment and treatment solutions.

CoreMapBurlington, VT, USMedical Devicesest. 2016CoreMapBurlington, VT, US · est. 2016

CoreMap: Enhancing patient outcomes with advanced diagnostic technology for electrophysiologists.

Series B · $33.8M35

CardioFocusMarlborough, MA, USMedical Devicesest. 1990CardioFocusMarlborough, MA, US · est. 1990

US-based CardioFocus advances ablation treatments for cardiac disorders through biotechnology.

Public · $268M71

AtriomxMenlo Park, CA, USMedical Devicesest. 2020AtriomxMenlo Park, CA, US · est. 2020

Atriomx offers non-invasive cardiac arrhythmia solutions using advanced data science for precise patient treatment.

Series A · $11M6

Leadership at Ajax Health

Aftab KheraniBoard Member

Garheng KongBoard Member

Similar to Ajax Health

AlopexxCambridge, MA, USMedical Devicesest. 2011AlopexxCambridge, MA, US · est. 2011

Alopexx: Investing in healthcare tech and partnering with entrepreneurs to launch novel medical solutions.

Health2047Menlo Park, CA, USHealthcare Solutionsest. 2015Health2047Menlo Park, CA, US · est. 2015

Health2047: A Silicon Valley firm innovating and commercializing transformative healthcare solutions.

Series B · $42.2M31

America Great HealthAlhambra, CA, USBiotechnology, Drugs, Medical Devicesest. 2013America Great HealthAlhambra, CA, US · est. 2013

America Great Health: A biotech firm innovating in drug R&D, AI diagnostics, cell therapy, and healthcare tech integration.

AgentixDana Point, CA, USBiopharmaceuticalsest. 2013AgentixDana Point, CA, US · est. 2013

Agentix, a biopharmaceutical firm, develops health solutions and modulates the ECS for therapeutic targets, based in California.

Public · $808.3k7